380 related articles for article (PubMed ID: 20889376)
1. Reassessment of the threshold of urinary cadmium by using hybrid approach in a cadmium non-polluted area in Japan.
Suwazono Y; Nogawa K; Uetani M; Kido T; Nakagawa H
Int J Hyg Environ Health; 2011 Mar; 214(2):175-8. PubMed ID: 20889376
[TBL] [Abstract][Full Text] [Related]
2. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand.
Nishijo M; Suwazono Y; Ruangyuttikarn W; Nambunmee K; Swaddiwudhipong W; Nogawa K; Nakagawa H
BMC Public Health; 2014 Jul; 14():702. PubMed ID: 25012790
[TBL] [Abstract][Full Text] [Related]
4. Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
J Appl Toxicol; 2006; 26(4):351-5. PubMed ID: 16791912
[TBL] [Abstract][Full Text] [Related]
5. Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan.
Kobayashi E; Suwazono Y; Dochi M; Honda R; Nishijo M; Kido T; Nakagawa H
Toxicol Lett; 2008 Jun; 179(2):108-12. PubMed ID: 18515022
[TBL] [Abstract][Full Text] [Related]
6. Application of the hybrid approach to the benchmark dose of urinary cadmium as the reference level for renal effects in cadmium polluted and non-polluted areas in Japan.
Suwazono Y; Nogawa K; Uetani M; Nakada S; Kido T; Nakagawa H
Environ Res; 2011 Feb; 111(2):312-4. PubMed ID: 21190684
[TBL] [Abstract][Full Text] [Related]
7. Estimation of benchmark doses for urinary cadmium based on beta2-microglobulin excretion in cadmium-polluted regions of the Kakehashi River basin, Japan.
Shimizu A; Kobayashi E; Suwazono Y; Uetani M; Oishi M; Inaba T; Kido T; Nogawa K
Int J Environ Health Res; 2006 Oct; 16(5):329-37. PubMed ID: 16990174
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.
Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M
Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302
[TBL] [Abstract][Full Text] [Related]
9. Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China.
Wang X; Wang Y; Feng L; Tong Y; Chen Z; Ying S; Chen T; Li T; Xia H; Jiang Z; Shang Q; Lou X; Lou J
PLoS One; 2016; 11(8):e0161240. PubMed ID: 27537182
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of cadmium toxicity in a Thai population with high-level environmental exposure.
Teeyakasem W; Nishijo M; Honda R; Satarug S; Swaddiwudhipong W; Ruangyuttikarn W
Toxicol Lett; 2007 Mar; 169(3):185-95. PubMed ID: 17306939
[TBL] [Abstract][Full Text] [Related]
11. Low-level cadmium exposure in Toyama City and its surroundings in Toyama prefecture, Japan, with references to possible contribution of shellfish intake to increase urinary cadmium levels.
Yamagami T; Ezaki T; Moriguchi J; Fukui Y; Okamoto S; Ukai H; Sakurai H; Aoshima K; Ikeda M
Sci Total Environ; 2006 Jun; 362(1-3):56-67. PubMed ID: 16169058
[TBL] [Abstract][Full Text] [Related]
12. Benchmark dose of cadmium concentration in rice for renal effects in a cadmium-polluted area in Japan.
Nogawa K; Kido T; Nishijo M; Nakagawa H; Suwazono Y
J Appl Toxicol; 2015 Jan; 35(1):24-8. PubMed ID: 24477824
[TBL] [Abstract][Full Text] [Related]
13. Benchmark dose for cadmium-induced osteoporosis in women.
Suwazono Y; Sand S; Vahter M; Skerfving S; Lidfeldt J; Akesson A
Toxicol Lett; 2010 Aug; 197(2):123-7. PubMed ID: 20493933
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in urinary levels of cadmium, N-acetyl-β-d-glucosaminidase and β2-microglobulin in individuals in a cadmium-contaminated area.
Kim YD; Yim DH; Eom SY; Moon SI; Park CH; Kim GB; Yu SD; Choi BS; Park JD; Kim H
Environ Toxicol Pharmacol; 2015 Jan; 39(1):35-41. PubMed ID: 25434760
[TBL] [Abstract][Full Text] [Related]
15. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
Hong F; Jin TY; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
[TBL] [Abstract][Full Text] [Related]
16. Recent applications of benchmark dose method for estimation of reference cadmium exposure for renal effects in man.
Suwazono Y; Uetani M; Akesson A; Vahter M
Toxicol Lett; 2010 Sep; 198(1):40-3. PubMed ID: 20420885
[TBL] [Abstract][Full Text] [Related]
17. Effects of low-dose cadmium exposure on biological examinations.
Nakadaira H; Nishi S
Sci Total Environ; 2003 Jun; 308(1-3):49-62. PubMed ID: 12738200
[TBL] [Abstract][Full Text] [Related]
18. Variation in benchmark dose (BMD) and the 95% lower confidence limit of benchmark dose (BMDL) among general Japanese populations with no anthropogenic exposure to cadmium.
Sakuragi S; Takahashi K; Hoshuyama T; Moriguchi J; Ohashi F; Fukui Y; Ikeda M
Int Arch Occup Environ Health; 2012 Nov; 85(8):941-50. PubMed ID: 22270387
[TBL] [Abstract][Full Text] [Related]
19. Benchmark Dose for Urinary Cadmium based on a Marker of Renal Dysfunction: A Meta-Analysis.
Woo HD; Chiu WA; Jo S; Kim J
PLoS One; 2015; 10(5):e0126680. PubMed ID: 25970611
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of cadmium exposure in cadmium nonpolluted areas in Japan.
Suwazono Y; Kobayashi E; Okubo Y; Nogawa K; Kido T; Nakagawa H
Environ Res; 2000 Sep; 84(1):44-55. PubMed ID: 10991781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
